Technical Analysis for BWAY - Brainsway Ltd.

Grade Last Price % Change Price Change
C 9.14 2.24% 0.20
BWAY closed up 4.56 percent on Monday, March 1, 2021, on 59 percent of normal volume.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Down
Historical BWAY trend table...

Date Alert Name Type % Chg
Crossed Above 20 DMA Bullish 2.24%
20 DMA Resistance Bearish 6.90%
Wide Bands Range Expansion 6.90%
Fell Below 20 DMA Bearish 4.58%
Wide Bands Range Expansion 4.58%
Crossed Above 20 DMA Bullish -1.51%
Volume Surge Other -1.51%
Wide Bands Range Expansion -1.51%
Fell Below 20 DMA Bearish 4.46%
MACD Bearish Signal Line Cross Bearish 4.46%
Older End-of-Day Signals for BWAY ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Rose Above Previous Day's High 31 minutes ago
Up 2% 31 minutes ago
Up 1% 31 minutes ago
20 DMA Support about 1 hour ago
60 Minute Opening Range Breakout about 1 hour ago
View Earlier Intraday Alerts

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Brainsway is a commercial stage medical device company focused on the development and sale of non-invasive neuromodulation products using the Company’s proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) technology for the treatment of major depressive disorder (MDD) and obsessive-compulsive disorder (OCD), for which Brainsway received marketing authorization from the U.S. Food and Drug Administration (FDA) in 2013 (for MDD) and in August 2018 (for OCD). Brainsway is currently conducting clinical trials of Deep TMS in other psychiatric, neurological and addiction disorders, including smoking cessation and post-traumatic stress disorder, and is planning trials for opioid addiction, fatigue in multiple sclerosis (MS) and post-stroke rehabilitation.
Classification

Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Neuroscience Mental Health Opioid FDA Multiple Sclerosis Stroke Psychiatry Depressive Disorder Major Depressive Disorder Smoking Neuromodulation Neurotechnology Smoking Cessation Neurophysiology Treatment Of Major Depressive Disorder Fatigue Obsessive Compulsive Disorder Addiction Neuromodulation Products Neuropsychology Post Traumatic Stress Disorder Treatment Of Depression

Is BWAY a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 11.0
52 Week Low 5.1
Average Volume 74,498
200-Day Moving Average 6.83
50-Day Moving Average 8.14
20-Day Moving Average 8.90
10-Day Moving Average 9.28
Average True Range 0.64
ADX 30.26
+DI 29.53
-DI 21.77
Chandelier Exit (Long, 3 ATRs ) 8.56
Chandelier Exit (Short, 3 ATRs ) 9.65
Upper Bollinger Band 10.16
Lower Bollinger Band 7.64
Percent B (%b) 0.52
BandWidth 28.37
MACD Line 0.23
MACD Signal Line 0.35
MACD Histogram -0.1129
Fundamentals Value
Market Cap 99.46 Million
Num Shares 11.1 Million
EPS -1.03
Price-to-Earnings (P/E) Ratio -8.70
Price-to-Sales 3.27
Price-to-Book 3.46
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 9.57
Resistance 3 (R3) 9.53 9.27 9.47
Resistance 2 (R2) 9.27 9.11 9.30 9.43
Resistance 1 (R1) 9.11 9.01 9.19 9.15 9.39
Pivot Point 8.85 8.85 8.90 8.88 8.85
Support 1 (S1) 8.69 8.69 8.77 8.73 8.49
Support 2 (S2) 8.43 8.59 8.46 8.45
Support 3 (S3) 8.27 8.43 8.42
Support 4 (S4) 8.31